Management of Acute Myeloid Leukemia in Young Adult in the Peripheral Area: A Case Report

Case Report

Authors

  • Clarissa Nadia Gultom General practitioner, Bangka Tengah Regional General Hospital, Koba City, Bangka Belitung, Indonesia,
  • Said Ansori Consultant in Internal Medicine, Bangka Tengah General Hospital, Koba, Bangka Belitung, Indonesia

DOI:

https://doi.org/10.55175/cdk.v53i06.1853

Keywords:

Acute myeloid leukemia, bone marrow, case report, hematopoietic malignancy, leukocytosis, myeloid

Abstract

Introduction: Acute myeloid leukemia (AML) is an aggressive and rapidly progressing hematopoietic malignancy that originates from myeloid stem cells in the bone marrow. Case: An 18-year-old male presented with nausea and vomiting for 5 days, preceded by frequent fatigue and weight loss over the past month. Vital signs were within normal limits. Physical examination revealed anemic conjunctivae and palpable enlargement of the liver and spleen. Laboratory examination revealed extreme leucocytosis, severe anemia, and thrombocytopenia. The patient was diagnosed with acute myeloid leukemia. Management was symptomatic with blood transfusion, and referred for further treatment. Discussion: AML is generally characterized by nonspecific symptoms such as anemia, fever, bleeding, hepatosplenomegaly, as well as hematological abnormalities including leukocytosis, anemia, and thrombocytopenia. The diagnosis is made by examining peripheral blood and bone marrow, while the prognosis is influenced by the patient's age, subtype, and cytogenetic abnormalities. Conclusion: AML in young adults may present with nonspecific symptoms such as fatigue, nausea, vomiting, and weight loss, which can delay diagnosis. Marked hematologic abnormalities, including extreme leukocytosis, severe anemia, and thrombocytopenia, should raise suspicion for AML. Early recognition, appropriate supportive management, and timely referral from peripheral healthcare facilities are essential to improve patient outcomes and survival.

Downloads

Download data is not yet available.

References

Pelcovits A, Niroula R. Acute myeloid leukemia: a review. R I Med J (2013) [Internet]. 2020;103(3):38–40. PMID: 32236160.

Stubbins RJ, Francis A, Kuchenbauer F, Sanford D. Management of acute myeloid leukemia: a review for general practitioners in oncology. Curr Oncol. 2022;29(9):6245–59. https://doi.org/10.3390/ curroncol29090491.

Vakiti A, Reynolds SB, Mewawalla P. Acute myeloid leukemia [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2026 May 28]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507875/.

Irawan C, Steven R, Gunarsa RG, Tenggara JB. Luaran Hasil Leukemia Mieloid Akut yang Menjalani Terapi pada Ruang Kemoterapi Semi-Isolasi. J Penyakit Dalam Indones. 2022;9(3):155. https://doi.org/10.7454/jpdi.v9i3.857

Bhansali RS, Pratz KW, Lai C. Recent advances in targeted therapies in acute myeloid leukemia. J Hematol Oncol. 2023;16(1):29. https://doi.org/10.1186/s13045-023-01424-6.

Karjalainen E, Repasky GA. Molecular changes during acute myeloid leukemia (AML) evolution and identification of novel treatment strategies through molecular stratification. Prog Mol Biol Transl Sci. 2016 Jan 1;144:383–436. https://doi.org/10.1016/bs.pmbts.2016.09.005.

Yuliana. Perkembangan terapi leukemia mieloid akut di RS Siloam Balikpapan. Cermin Dunia Kedokt. 2017;44(3):216–20. https://doi.org/10.55175/cdk.v44i3.835.

Khwaja A, Bjorkholm M, Gale RE, Levine RL, Jordan CT, Ehninger G, et al. Acute myeloid leukaemia. Nat Rev Dis Prim, 2024;147(2):229–46. https://doi.org/10.1038/nrdp.2016.10

Wachter F, Pikman Y. Pathophysiology of acute myeloid leukemia. Acta Haematologica. 2024;147:232–49. https://doi.org/10.1159/000536152.

Nagar V, Patil N, Gudur A, Gudur R. Clinicopathological study of acute myeloid leukemia in a tertiary care hospital. Int J Health Sci (Qassim). 2022 Apr 8;II:3070–7. https://doi.org/10.53730/ijhs.v6nS2.5735.

Kabel AM, Zamzami F, Al-Talhi M, Al-Dwila K, Hamza R. Acute myeloid leukemia: a focus on risk factors, clinical presentation, diagnosis and possible lines of management. J Cancer Res Treat. 2017;5(2):62–7. https://doi.org/10.12691/jcrt-5-2-4.

Misirlioglu M, Adisen MZ, Yilmaz S. Diagnosis of acute myeloid leukemia in a dental hospital; report of a case with severe gingival hypertrophy. Niger J Clin Pract. 2015 Jul 1;18(4):573–6. https://doi.org/10.4103/1119-3077.151803.

Trentino KM, Farmer SL, Leahy MF, Sanfilippo FM, Isbister JP, Mayberry R, et al. Systematic reviews and meta-analyses comparing mortality in restrictive and liberal haemoglobin thresholds for red cell transfusion: an overview of systematic reviews. BMC Med. 2024;18(1):154. https://doi.org/10.1186/s12916-020-01614-w.

Chan KY, Chan TSY, Gill H, Chan TCW, Li CW, Au HY, et al. Supportive care and symptom management in patients with advanced hematological malignancies: a literature review. Ann Palliat Med. 2022;11(10):3273–91. doi: 10.21037/apm-22-691.

Mouchel PL, Berard E, Tavitian S, Gadaud N, Vergez F, Rieu JB, et al. Vitamin C and D supplementation in acute myeloid leukemia. Blood Adv. 2023;7(22):6886–97. doi: 10.1182/bloodadvances.2023010559.

Hastuti TS, Sumantri R, Wijaya I. Complete remission of acute myeloid leukemia in induction and consolidation chemotherapy without bone marrow transplantation: lessons learned from good presentation case. Maj Kedokt Bandung. 2019;51(1):31–8. https://doi.org/10.15395/mkb.v51n1.1634.

Downloads

Published

15-06-2026

How to Cite

Gultom, C. N., & Ansori, S. (2026). Management of Acute Myeloid Leukemia in Young Adult in the Peripheral Area: A Case Report: Case Report. Cermin Dunia Kedokteran, 53(06), 406–409. https://doi.org/10.55175/cdk.v53i06.1853

Issue

Section

Articles